Cancer News 3/3

The Way Forward Is Clearer, Together.

The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.

Intrauterine Device May Reduce Ovarian Cancer Risk by 30%

Women who have ever used an intrauterine device (IUD) for birth control may have a 30% lower risk for ovarian cancer.

Women's Cancer Research Foundation

Nov 3, 20211 min read

Genital Powder Use and Epithelial Ovarian Cancer

Beginning in 2014, several lawsuits were filed against companies with talc products (baby powder) on behalf of women with ovarian cancer.

Women's Cancer Research Foundation

Oct 30, 20212 min read

No Survival Benefit from Annual Ovarian Cancer Screening in Low-Risk Women

The lifetime risk of developing ovarian cancer in women who are not genetically susceptible to the disease is approximately 2%.

Women's Cancer Research Foundation

Oct 27, 20212 min read

Women’s Health: 50 Years of Progress

Over the past 50 years, there have been tremendous advances in women’s health, particularly in treating cardiovascular disease and cancer.

Women's Cancer Research Foundation

Oct 16, 20212 min read

Improved Ovarian Cancer Patient Survival Rates for Patients With bevacizumab

For the past ten yrs, continued use of bevacizumab therapy in the first-line treatment of ovarian cancer has reportedly improved...

Women's Cancer Research Foundation

Oct 14, 20211 min read

Risk of Late-Onset Breast Cancer in Genetically Predisposed Women

Germline mutations in breast cancer predispose women to develop this malignancy, but in woman 65+years, the risk is not well-defined.

Women's Cancer Research Foundation

Oct 12, 20211 min read

Combination Strategies Reshape Treatment Paradigm for Advanced Endometrial Cancer

Initially, pembrolizumab was approved as a monotherapy for patients with microsatellite instability-high recurrent endometrial cancer.

Women's Cancer Research Foundation

Oct 8, 20211 min read

Blood Test for Many Cancer Types as Supplement to Screening

The blood test uses next-generation sequencing to analyze the arrangement of circulating cell-free DNA from a blood sample.

Women's Cancer Research Foundation

Oct 5, 20211 min read

Women With Ovarian Cancer at Higher Risk for Mental Health Disorders

Ovarian cancer survivors who had a mental health diagnosis demonstrated an 80% higher risk for mortality.

Women's Cancer Research Foundation

Aug 31, 20212 min read

Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers

Oral contraceptive use potentially reduces the risk of breast, ovarian, and endometrial cancers.

Women's Cancer Research Foundation

Aug 12, 20211 min read

Drug Boosts Survival for Women with Advanced Ovarian Cancer

Lynparza (Olaparib), a targeted cancer therapy, has recently shown a meaningful survival benefit after 5 years.

Women's Cancer Research Foundation

Aug 5, 20211 min read

Appropriateness of Specific Chemotherapy Regimens in Elderly Patients Diagnosed with Ovarian Cancer

Efficacy and safety of first-line single-agent carboplatin vs carboplatin plus paclitaxel for vulnerable older adult women with ovarian....

Women's Cancer Research Foundation

Jul 5, 20211 min read

Sleep quality and related factors in patients with breast cancer: A cross- sectional study in Taiwan

Researchers studied various factors related to post-treatment sleep disturbances in breast cancer patients.

Women's Cancer Research Foundation

Jun 30, 20211 min read

Associations Between Multimorbidity and Depression in Breast Cancer Survivors

Researchers used the UK Biobank (a national biomedical database) to examine the link between multimorbidity and depression.

Women's Cancer Research Foundation

Jun 23, 20211 min read

New blood test could reveal undiagnosed ovarian cancer in thousands of women

Researchers have developed a screening test for ovarian cancer that potentially detects the disease at earlier stages.

Women's Cancer Research Foundation

Jun 10, 20211 min read

HPV-Related Cancers Are on the Rise

With the Exception of Cervical Cancer, HPV-Related Cancers Are on the Rise, Especially in Older Adults

Women's Cancer Research Foundation

Jun 3, 20212 min read

For Ovarian Cancer Survivors, Exercise Can Lift Spirits

A recent study from the Yale School of Public Health reported that routine exercise may reduce the incidence of depression among ovarian

Women's Cancer Research Foundation

May 19, 20211 min read

World Ovarian Cancer Day - Promising Research

May 8th marks World Ovarian Cancer Day, and annually, it's an opportunity to globally embrace solidarity in the fight against ovarian cancer

Women's Cancer Research Foundation

May 7, 20211 min read

Secondary cytoreduction followed by chemotherapy vs chemotherapy alone

Secondary cytoreduction followed by chemotherapy vs chemotherapy alone in platinum-sensitive relapsed ovarian cancer

Women's Cancer Research Foundation

Apr 29, 20212 min read

Endometrial Cancer Risk in Women Diagnosed with a Germline BRCA1 or BRCA2 Mutation

BRCA1 and BRCA2 are genes that produce proteins that help repair damaged DNA (a person’s unique genetic code).

Women's Cancer Research Foundation

Apr 7, 20212 min read